Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 133

1.

SNF472, a novel anti-crystallization agent, inhibits induced calcification in an in vitro model of human aortic valve calcification.

Zabirnyk A, Ferrer MD, Bogdanova M, Pérez MM, Salcedo C, Kaljusto ML, Kvitting JP, Stensløkken KO, Perelló J, Vaage J.

Vascul Pharmacol. 2019 Aug 19:106583. doi: 10.1016/j.vph.2019.106583. [Epub ahead of print]

2.

Improvement in wound healing, pain, and quality of life after 12 weeks of SNF472 treatment: a phase 2 open-label study of patients with calciphylaxis.

Brandenburg VM, Sinha S, Torregrosa JV, Garg R, Miller S, Canals AZ, Bahr D, Joubert PH, Salcedo C, Carroll KJ, Gold A, Perelló J.

J Nephrol. 2019 Oct;32(5):811-821. doi: 10.1007/s40620-019-00631-0. Epub 2019 Aug 10.

PMID:
31401795
3.

A phase 1b randomized, placebo-controlled clinical trial with SNF472 in haemodialysis patients.

Salcedo C, Joubert PH, Ferrer MD, Canals AZ, Maduell F, Torregrosa V, Campistol JM, Ojeda R, Perelló J.

Br J Clin Pharmacol. 2019 Apr;85(4):796-806. doi: 10.1111/bcp.13863. Epub 2019 Feb 19.

PMID:
30632182
4.

Citizen Social Lab: A digital platform for human behavior experimentation within a citizen science framework.

Vicens J, Perelló J, Duch J.

PLoS One. 2018 Dec 6;13(12):e0207219. doi: 10.1371/journal.pone.0207219. eCollection 2018.

5.

Resource heterogeneity leads to unjust effort distribution in climate change mitigation.

Vicens J, Bueno-Guerra N, Gutiérrez-Roig M, Gracia-Lázaro C, Gómez-Gardeñes J, Perelló J, Sánchez A, Moreno Y, Duch J.

PLoS One. 2018 Oct 31;13(10):e0204369. doi: 10.1371/journal.pone.0204369. eCollection 2018.

6.

First-time-in-human randomized clinical trial in healthy volunteers and haemodialysis patients with SNF472, a novel inhibitor of vascular calcification.

Perelló J, Joubert PH, Ferrer MD, Canals AZ, Sinha S, Salcedo C.

Br J Clin Pharmacol. 2018 Dec;84(12):2867-2876. doi: 10.1111/bcp.13752. Epub 2018 Oct 3.

PMID:
30280390
7.

Author Correction: Quantitative account of social interactions in a mental health care ecosystem: cooperation, trust and collective action.

Cigarini A, Vicens J, Duch J, Sánchez A, Perelló J.

Sci Rep. 2018 Sep 26;8(1):14595. doi: 10.1038/s41598-018-32562-4.

8.

Characterization of SNF472 pharmacokinetics and efficacy in uremic and non-uremic rats models of cardiovascular calcification.

Ferrer MD, Ketteler M, Tur F, Tur E, Isern B, Salcedo C, Joubert PH, Behets GJ, Neven E, D'Haese PC, Perelló J.

PLoS One. 2018 May 9;13(5):e0197061. doi: 10.1371/journal.pone.0197061. eCollection 2018.

9.

Characterization of the population with severe iron deficiency anemia at risk of requiring intravenous iron supplementation.

Estadella J, Villamarín L, Feliu A, Perelló J, Calaf J.

Eur J Obstet Gynecol Reprod Biol. 2018 May;224:41-44. doi: 10.1016/j.ejogrb.2018.03.005. Epub 2018 Mar 6.

PMID:
29529476
10.

Quantitative account of social interactions in a mental health care ecosystem: cooperation, trust and collective action.

Cigarini A, Vicens J, Duch J, Sánchez A, Perelló J.

Sci Rep. 2018 Feb 28;8(1):3794. doi: 10.1038/s41598-018-21900-1. Erratum in: Sci Rep. 2018 Sep 26;8(1):14595.

11.

SNF472, a novel inhibitor of vascular calcification, could be administered during hemodialysis to attain potentially therapeutic phytate levels.

Perelló J, Gómez M, Ferrer MD, Rodríguez NY, Salcedo C, Buades JM, Pérez MM, Torregrosa JV, Martín E, Maduell F.

J Nephrol. 2018 Apr;31(2):287-296. doi: 10.1007/s40620-018-0471-9. Epub 2018 Jan 19.

12.

Ulipristal acetate for the management of acute heavy menstrual bleeding without fibroids.

Estadella J, Español P, Ascencio F, Perelló J, Calaf J.

Gynecol Endocrinol. 2018 Jul;34(7):554-557. doi: 10.1080/09513590.2017.1417376. Epub 2017 Dec 20.

PMID:
29260904
13.

A novel pharmacodynamic assay to evaluate the effects of crystallization inhibitors on calcium phosphate crystallization in human plasma.

Ferrer MD, Pérez MM, Cànaves MM, Buades JM, Salcedo C, Perelló J.

Sci Rep. 2017 Jul 31;7(1):6858. doi: 10.1038/s41598-017-07203-x.

14.

Market Imitation and Win-Stay Lose-Shift Strategies Emerge as Unintended Patterns in Market Direction Guesses.

Gutiérrez-Roig M, Segura C, Duch J, Perelló J.

PLoS One. 2016 Aug 17;11(8):e0159078. doi: 10.1371/journal.pone.0159078. eCollection 2016.

15.

Humans display a reduced set of consistent behavioral phenotypes in dyadic games.

Poncela-Casasnovas J, Gutiérrez-Roig M, Gracia-Lázaro C, Vicens J, Gómez-Gardeñes J, Perelló J, Moreno Y, Duch J, Sánchez A.

Sci Adv. 2016 Aug 5;2(8):e1600451. doi: 10.1126/sciadv.1600451. eCollection 2016 Aug.

16.

Hypothesis: Phytate is an important unrecognised nutrient and potential intravenous drug for preventing vascular calcification.

Joubert P, Ketteler M, Salcedo C, Perello J.

Med Hypotheses. 2016 Sep;94:89-92. doi: 10.1016/j.mehy.2016.07.005. Epub 2016 Jul 12.

PMID:
27515210
17.

Active and reactive behaviour in human mobility: the influence of attraction points on pedestrians.

Gutiérrez-Roig M, Sagarra O, Oltra A, Palmer JR, Bartumeus F, Díaz-Guilera A, Perelló J.

R Soc Open Sci. 2016 Jul 13;3(7):160177. doi: 10.1098/rsos.160177. eCollection 2016 Jul.

18.

Direct Covalent Grafting of Phytate to Titanium Surfaces through Ti-O-P Bonding Shows Bone Stimulating Surface Properties and Decreased Bacterial Adhesion.

Córdoba A, Hierro-Oliva M, Pacha-Olivenza MÁ, Fernández-Calderón MC, Perelló J, Isern B, González-Martín ML, Monjo M, Ramis JM.

ACS Appl Mater Interfaces. 2016 May 11;8(18):11326-35. doi: 10.1021/acsami.6b02533. Epub 2016 Apr 27.

PMID:
27088315
19.

Relationship between Urinary Level of Phytate and Valvular Calcification in an Elderly Population: A Cross-Sectional Study.

Fernández-Palomeque C, Grau A, Perelló J, Sanchis P, Isern B, Prieto RM, Costa-Bauzá A, Caldés OJ, Bonnin O, Garcia-Raja A, Bethencourt A, Grases F.

PLoS One. 2015 Aug 31;10(8):e0136560. doi: 10.1371/journal.pone.0136560. eCollection 2015.

20.

Mechanistic insights into protonation state as a critical factor in hFPPS enzyme inhibition.

Fernández D, Ortega-Castro J, Mariño L, Perelló J, Frau J.

J Comput Aided Mol Des. 2015 Jul;29(7):667-80. doi: 10.1007/s10822-015-9853-4. Epub 2015 Jun 17.

PMID:
26081258
21.

Value of the future: Discounting in random environments.

Farmer JD, Geanakoplos J, Masoliver J, Montero M, Perelló J.

Phys Rev E Stat Nonlin Soft Matter Phys. 2015 May;91(5):052816. Epub 2015 May 28.

22.

Transition from reciprocal cooperation to persistent behaviour in social dilemmas at the end of adolescence.

Gutiérrez-Roig M, Gracia-Lázaro C, Perelló J, Moreno Y, Sánchez A.

Nat Commun. 2014 Jul 15;5:4362. doi: 10.1038/ncomms5362.

PMID:
25025603
23.

Phytate levels in biological fluids of mammals.

Perelló J, Grases F.

J Chromatogr B Analyt Technol Biomed Life Sci. 2014 Jun 1;960:255-7. doi: 10.1016/j.jchromb.2013.12.016. Epub 2013 Dec 27. No abstract available.

PMID:
24411273
24.

Validation of an LC-MS bioanalytical method for quantification of phytate levels in rat, dog and human plasma.

Tur F, Tur E, Lentheric I, Mendoza P, Encabo M, Isern B, Grases F, Maraschiello C, Perelló J.

J Chromatogr B Analyt Technol Biomed Life Sci. 2013 Jun 1;928:146-54. doi: 10.1016/j.jchromb.2013.03.023. Epub 2013 Apr 8.

PMID:
23639799
25.

Differential response of MC3T3-E1 and human mesenchymal stem cells to inositol hexakisphosphate.

Arriero Mdel M, Ramis JM, Perelló J, Monjo M.

Cell Physiol Biochem. 2012;30(4):974-86. doi: 10.1159/000341474. Epub 2012 Sep 20.

26.

First-passage and escape problems in the Feller process.

Masoliver J, Perelló J.

Phys Rev E Stat Nonlin Soft Matter Phys. 2012 Oct;86(4 Pt 1):041116. Epub 2012 Oct 10. Erratum in: Phys Rev E Stat Nonlin Soft Matter Phys. 2012 Oct;86(4 Pt 2):049906. Phys Rev E Stat Nonlin Soft Matter Phys. 2014 Feb;89(2):029902.

PMID:
23214538
27.

Inositol hexakisphosphate inhibits osteoclastogenesis on RAW 264.7 cells and human primary osteoclasts.

Arriero Mdel M, Ramis JM, Perelló J, Monjo M.

PLoS One. 2012;7(8):e43187. doi: 10.1371/journal.pone.0043187. Epub 2012 Aug 14.

28.

Protective effect of myo-inositol hexaphosphate (phytate) on bone mass loss in postmenopausal women.

López-González AA, Grases F, Monroy N, Marí B, Vicente-Herrero MT, Tur F, Perelló J.

Eur J Nutr. 2013 Mar;52(2):717-26. doi: 10.1007/s00394-012-0377-6. Epub 2012 May 22.

PMID:
22614760
29.

Scaling properties and universality of first-passage-time probabilities in financial markets.

Perelló J, Gutiérrez-Roig M, Masoliver J.

Phys Rev E Stat Nonlin Soft Matter Phys. 2011 Dec;84(6 Pt 2):066110. Epub 2011 Dec 14.

PMID:
22304158
30.

Urinary lithogenesis risk tests: comparison of a commercial kit and a laboratory prototype test.

Grases F, Costa-Bauzá A, Prieto RM, Arrabal M, De Haro T, Lancina JA, Barbuzano C, Colom S, Riera J, Perelló J, Isern B, Sanchis P, Conte A, Barragan F, Gomila I.

Scand J Urol Nephrol. 2011 Nov;45(5):312-8. doi: 10.3109/00365599.2011.584551. Epub 2011 Jun 20.

PMID:
21682577
31.

Effect of tetracalcium dimagnesium phytate on bone characteristics in ovariectomized rats.

Grases F, Sanchis P, Prieto RM, Perelló J, López-González ÁA.

J Med Food. 2010 Dec;13(6):1301-6. doi: 10.1089/jmf.2009.0152.

PMID:
21091244
32.

Vascular injury by tacks during totally extraperitoneal endoscopic inguinal hernioplasty.

Moreno-Egea A, Paredes PG, Perello JM, Campillo-Soto A, Baena EG, Muñoz JR, Aguayo-Albasini JL.

Surg Laparosc Endosc Percutan Tech. 2010 Jun;20(3):e129-31. doi: 10.1097/SLE.0b013e3181df22a8.

PMID:
20551793
33.

Phytate levels and bone parameters: a retrospective pilot clinical trial.

Lopez-Gonzalez AA, Grases F, Perello J, Tur F, Costa-Bauza A, Monroy N, Mari B, Vicente-Herrero T.

Front Biosci (Elite Ed). 2010 Jun 1;2:1093-8.

PMID:
20515779
34.

Effects of Mediterranean diets with low and high proportions of phytate-rich foods on the urinary phytate excretion.

Prieto RM, Fiol M, Perello J, Estruch R, Ros E, Sanchis P, Grases F.

Eur J Nutr. 2010 Sep;49(6):321-6. doi: 10.1007/s00394-009-0087-x. Epub 2010 Jan 28.

PMID:
20108098
35.

Evolution of post-ESWL residual lithiasis depending on the type of calculus and urine composition.

Grases F, Costa-Bauzá A, Isern B, Sanchis P, Perelló J, Hierro F, Conte Visus A.

Arch Esp Urol. 2009 Jul;62(6):473-82. English, Spanish.

PMID:
19736377
36.

First-passage and risk evaluation under stochastic volatility.

Masoliver J, Perelló J.

Phys Rev E Stat Nonlin Soft Matter Phys. 2009 Jul;80(1 Pt 2):016108. Epub 2009 Jul 13.

PMID:
19658775
37.

Escape problem under stochastic volatility: the Heston model.

Masoliver J, Perelló J.

Phys Rev E Stat Nonlin Soft Matter Phys. 2008 Nov;78(5 Pt 2):056104. Epub 2008 Nov 7.

PMID:
19113187
38.

Anticalculus effect of a triclosan mouthwash containing phytate: a double-blind, randomized, three-period crossover trial.

Grases F, Perelló J, Sanchis P, Isern B, Prieto RM, Costa-Bauzá A, Santiago C, Ferragut ML, Frontera G.

J Periodontal Res. 2009 Oct;44(5):616-21. doi: 10.1111/j.1600-0765.2008.01168.x. Epub 2008 Oct 22.

PMID:
18973518
39.

Model for interevent times with long tails and multifractality in human communications: an application to financial trading.

Perelló J, Masoliver J, Kasprzak A, Kutner R.

Phys Rev E Stat Nonlin Soft Matter Phys. 2008 Sep;78(3 Pt 2):036108. Epub 2008 Sep 8.

PMID:
18851106
40.

Phytate reduces age-related cardiovascular calcification.

Grases F, Sanchis P, Perello J, Isern B, Prieto RM, Fernandez-Palomeque C, Saus C.

Front Biosci. 2008 May 1;13:7115-22.

PMID:
18508720
41.

Phytate inhibits bovine pericardium calcification in vitro.

Grases F, Sanchis P, Costa-Bauzá A, Bonnin O, Isern B, Perelló J, Prieto RM.

Cardiovasc Pathol. 2008 May-Jun;17(3):139-45. doi: 10.1016/j.carpath.2007.08.005. Epub 2007 Oct 24.

PMID:
18402805
42.

Volatility: a hidden Markov process in financial time series.

Eisler Z, Perelló J, Masoliver J.

Phys Rev E Stat Nonlin Soft Matter Phys. 2007 Nov;76(5 Pt 2):056105. Epub 2007 Nov 9.

PMID:
18233716
43.

Effect of crystallization inhibitors on vascular calcifications induced by vitamin D: a pilot study in Sprague-Dawley rats.

Grases F, Sanchis P, Perelló J, Isern B, Prieto RM, Fernández-Palomeque C, Torres JJ.

Circ J. 2007 Jul;71(7):1152-6.

44.

Extreme times for volatility processes.

Masoliver J, Perelló J.

Phys Rev E Stat Nonlin Soft Matter Phys. 2007 Apr;75(4 Pt 2):046110. Epub 2007 Apr 19.

PMID:
17500964
45.

Uric acid as inducer of calcium oxalate crystal development.

Grases F, Sanchis P, Isern B, Perelló J, Costa-Bauzá A.

Scand J Urol Nephrol. 2007;41(1):26-31.

PMID:
17366099
46.

Phytate acts as an inhibitor in formation of renal calculi.

Grases F, Isern B, Sanchis P, Perello J, Torres JJ, Costa-Bauza A.

Front Biosci. 2007 Jan 1;12:2580-7.

PMID:
17127264
47.

Anxiety and stress among science students. Study of calcium and magnesium alterations.

Grases G, Pérez-Castelló JA, Sanchis P, Casero A, Perelló J, Isern B, Rigo E, Grases F.

Magnes Res. 2006 Jun;19(2):102-6.

48.

Absorption of myo-inositol hexakisphosphate (InsP6) through the skin in humans.

Grases F, Isern B, Perelló J, Sanchis P, Prieto RM, Costa-Bauzà A.

Pharmazie. 2006 Jul;61(7):652.

PMID:
16889078
49.

Factors affecting calcium oxalate dihydrate fragmented calculi regrowth.

Costa-Bauzá A, Perelló J, Isern B, Sanchis P, Grases F.

BMC Urol. 2006 Jul 5;6:16.

50.

Role of uric acid in different types of calcium oxalate renal calculi.

Grases F, Sanchis P, Perelló J, Costa-Bauzá A.

Int J Urol. 2006 Mar;13(3):252-6.

Supplemental Content

Loading ...
Support Center